<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pierzynowska K</submitter><funding>Narodowe Centrum Nauki</funding><pagination>3363-3370</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7461230</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>594(20)</volume><pubmed_abstract>We used transcriptomic (RNA-seq) analyses to determine whether patients suffering from all types and subtypes of mucopolysaccharidosis (MPS), a severe inherited metabolic disease, may be more susceptible to coronavirus disease 2019 (COVID-19). The expression levels of genes encoding proteins potentially involved in SARS-CoV-2 development were estimated in MPS cell lines. Four genes (GTF2F2, RAB18, TMEM97, PDE4DIP) coding for proteins potentially facilitating virus development were down-regulated, while two genes (FBN1, MFGE8), the products of which potentially interfere with virus propagation, were up-regulated in most MPS types. Although narrowing of respiratory tract and occurrence of thick mucus, characteristic of MPS, are risk factors for COVID-19, transcriptomic analyses suggest that </pubmed_abstract><journal>FEBS letters</journal><pubmed_title>Transcriptomic analyses suggest that mucopolysaccharidosis patients may be less susceptible to COVID-19.</pubmed_title><pmcid>PMC7461230</pmcid><funding_grant_id>2017/25/B/NZ2/00414</funding_grant_id><pubmed_authors>Pierzynowska K</pubmed_authors><pubmed_authors>Gaffke L</pubmed_authors><pubmed_authors>Wegrzyn G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Transcriptomic analyses suggest that mucopolysaccharidosis patients may be less susceptible to COVID-19.</name><description>We used transcriptomic (RNA-seq) analyses to determine whether patients suffering from all types and subtypes of mucopolysaccharidosis (MPS), a severe inherited metabolic disease, may be more susceptible to coronavirus disease 2019 (COVID-19). The expression levels of genes encoding proteins potentially involved in SARS-CoV-2 development were estimated in MPS cell lines. Four genes (GTF2F2, RAB18, TMEM97, PDE4DIP) coding for proteins potentially facilitating virus development were down-regulated, while two genes (FBN1, MFGE8), the products of which potentially interfere with virus propagation, were up-regulated in most MPS types. Although narrowing of respiratory tract and occurrence of thick mucus, characteristic of MPS, are risk factors for COVID-19, transcriptomic analyses suggest that </description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Oct</publication><modification>2026-05-02T22:44:45.946Z</modification><creation>2025-04-25T18:11:58.731Z</creation></dates><accession>S-EPMC7461230</accession><cross_references><pubmed>32880920</pubmed><doi>10.1002/1873-3468.13908</doi></cross_references></HashMap>